We propose that the utility of the STRESS signature is such that it predicts how a tumor will dynamically respond to STAT3 signaling resulting from inflammation and oxidative stress and identifies tumors likely to respond to STAT3-targeted therapies. This evidence concerns the gene STAT3 and neoplasm.